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Background: Little is known about the impact of the reason for revision total hip arthroplasty (THA) on the
outcomes following revision THA. In this study, our objective was to assess the association of operative diagnosis
with patient-reported outcomes (PROs) after revision THA.
Methods: We used prospectively collected data from the Mayo Clinic Total Joint Registry that collects pre- and
post-operative pain and function outcomes using a validated Hip questionnaire, on all revision THAs from
1993–2005. We used logistic regression to assess the odds of moderate-severe index hip pain and moderate-severe
limitation in activities of daily living (ADLs) 2- and 5-years after revision THA. We calculated odds ratios (OR) and
95% confidence intervals (CIs).
Results: For the 2- and 5-year cohorts, the operative diagnosis was loosening/wear/osteolysis in 73% and 75%;
dislocation/bone or prosthesis fracture/instability or non-union in 17% and 15%; and failed prior arthroplasty with
components removed/infection in 11% and 11%, respectively. In multivariable-adjusted analyses that included
preoperative ADL limitations, compared to patients with loosening/wear/osteolysis, patients with dislocation/
fracture/instability/non-union had OR of 2.2 (95% CI, 1.3-3.5; p = 0.002) for overall moderate-severe ADL limitation
and those with failed prior arthroplasty/infection had OR of 1.6 (95% CI, 1.0-2.8; p = 0.06). At 5-years, ORs were lower
and differences were no longer significant. Moderate-severe pain did not differ significantly by diagnosis, at 2- or
5-years in multivariable adjusted analyses, with one exception, i.e. failed prior arthroplasty/infection had a trend
towards significance with odds ratio of 1.9 (95% CI, 0.9-3.8; p = 0.07).
Conclusions: Operative diagnosis is independently associated with ADL limitations, but not pain, at 2-years after
revision THA. Patients should be informed of the risk of poorer short-term outcomes based on their diagnosis.
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Revision total hip arthroplasty (THA) is a common
procedure performed for improvement in pain and
function in patients who have previously undergone
primary THA [1]. Among arthroplasty procedures, revi-
sion THA is a common procedure. The annual volume
of revision THA is increasing rapidly [2,3]. Based on
the National Inpatient Sample (NIS) sample, compared* Correspondence: Jasvinder.md@gmail.com
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distribution, and reproduction in any mediumto 40,800 revision THAs performed in in 2005, it is
projected that the volume will increase by 137% to
96,700 annually by year 2030 [3].
The increase in the volume of revision THA at 137%
is not too dissimilar to that of primary THA projected
to increase by 174% in the same period [3]. On the other
hand, most published literature has focused on predic-
tors of outcomes in patients with primary THA, with
very few studies focusing on revision THA. One import-
ant potential predictor of outcomes is the operative diag-
nosis for revision THA, but even fewer studies have
examined this association. In a previous study, patients
undergoing revision for loosening had better functionalCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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up compared to other diagnoses (infection, instability or
fracture) [4]. A recent study found that functional
improvements were lower in patients with infection
compared to patients with mechanical or pain causes for
revision hip arthroplasty [5]. Other studies of predictors
of outcomes after revision THA have reported the
following variables to be associated: better preoperative
pain scores and fewer comorbidities with functional out-
comes [6]; higher comorbidity with major complications
[7]; younger age, obesity and depression [8], higher body
mass index (BMI) [9], and female gender with worse
pain outcomes [4,8,10]; and higher BMI and worse pre-
operative scores with worse composite pain and function
outcome [11].
The objective of this study was to examine whether
the operative diagnosis was associated with pain and
function outcomes in patients undergoing revision THA.
We hypothesized that the (1) operative diagnosis of
loosening, wear or osteolysis will be associated with
better pain and function outcomes at both 2- and 5-
years post-revision THA compared to other diagnoses
and (2) that the association will be attenuated by adjust-
ment for preoperative status and other covariates.
Methods
We describe the methods and results as recommended
in the Strengthening of Reporting in Observational stud-
ies in Epidemiology (STROBE) statement [12].
Setting and participants
In this observational cohort study, we used prospectively
collected data from the Mayo Clinic Total Joint Registry,
a large U.S. institutional registry that collects data on
every patient who undergoes hip arthroplasty at the
Mayo Clinic, Rochester [13,14]. At 2- and 5-years
validated pain and function surveys are administered to
patients at the clinic visit, by mail or on the telephone,
by trained, registry staff. The Mayo Hip questionnaire
has been validated [13-15]. Several papers using these
data have been published [8,16]. Patients were included
in this study if they underwent revision THA between
1993 and 2005 and completed either a 2- or 5-year
patient survey. The study was approved by the Mayo
Clinic Institutional Review Board.
Outcomes of interest
We used the Mayo Hip questionnaire, a validated instru-
ment [13-15], as the source for both PROs of interest,
overall moderate-severe ADL limitation and moderate-
severe pain 2- or 5-years after revision THA. We catego-
rized the responses to limitations in seven activities
including walking, climbing stairs, putting on shoes/
socks, picking up objects from the floor, sitting, gettingin/out of the car, rising from chair into ‘no’, ‘mild’, ‘mod-
erate’ or ‘severe’ limitation for each activity. Presence of
≥3 activities with moderate or severe limitation was clas-
sified as overall moderate-severe ADL limitation (refer-
ence, no/mild ADL limitation), as previously [8,17]. The
pain question, similar to the pain question in Harris Hip
Score, a validated THA outcome instrument [18-20],
stated “How much pain do you have in your operated
hip?” Patients could respond- ‘none’, ‘mild’, ‘moderate’ or
‘severe’. None/mild pain was the reference category and
moderate and severe categories were combined into
moderate-severe pain, based on an a priori decision be-
fore data analyses, as in previous studies [8,16]. These a
priori decisions were based on recommendations from
an experienced orthopedic surgeon (D.G.L.), who viewed
moderate-severe ADL limitation or pain as undesirable
outcomes of arthroplasty.
Predictor of interest
Operative diagnosis was the main predictor of interest.
Based on a priori decision, diagnoses were lumped into
3 categories, as previously [8,21-23]: (1) loosening, wear
or osteolysis; (2) dislocation, bone or prosthesis fracture,
instability or non-union; and (3) failed prior arthroplasty
with components removed or infection.
Covariates of interest
Since several clinical, demographic and implant related
factors have been previously shown to be associated with
outcomes after THA, they were included in the analyses
as covariates and potential confounders [8,11,16]. These
included: (1) demographic factors- age and gender; (2)
clinical factors - body mass index (BMI) [24], American
Society of Anesthesiologists (ASA) class [25,26], depres-
sion, anxiety and medical comorbidity which was assessed
by Deyo-Charlson index, a validated comorbidity measure
[27], consisting of 17 comorbidities [28,29], based on the
presence of International Classification of Diseases- ninth
revision (ICD)-9 codes; (3) distance from the medical
center; and (4) preoperative limitation in 7 ADLs or
preoperative pain, in the respective model. As previously,
age was categorized into ≤60, 61–70, 71–80 and >80, BMI
into ≤25, 25.1-29.9, 30–34.9, 35–39.9 and ≥40, ASA class
into I-II vs. III-IV [8,16] and distance from the medical
center into 0–100 miles, >100-500 miles, >500 miles
[24,30,31]. Depression and anxiety were assessed by
the presence of ICD-9 codes in medical records
before the THA.
Data sources
Data on the dates of the THA, demographic details (age,
gender), BMI, ASA class, operative diagnosis, distance
from the medical center and preoperative limitation in 7
ADLs and preoperative pain were obtained from the
Table 1 Clinical characteristics of revision THA cohorts
Mean ± standard
deviation or n (%)
2-yr FU 5-yr FU
(n = 2,687) (n = 1,627)
Age 66 ± 13 65 ± 13
% female 54% 54%
BMI (kg/m2) 28 ± 6 28 ± 6
Age groups
≤60 yrs 30% 32%
>60-70 yrs 27% 29%
>70-80 yrs 34% 32%








Class I 3% 4%
Class II 49% 53%
Class III 47% 43%
Class IV <1% <1%
Operative diagnoses
Loosening/Wear or Osteolysis 73% 75%
Dislocation, Bone or Prosthesis
Fracture, Instability, Non-Union
17% 15%
Failed Prior Arthroplasty with
Components Removed or Infection
11% 11%
Deyo-Charlson Index 1 ± 2 1 ± 1
Depression 6% 6%
Anxiety 3% 3%
--, not applicable; numbers rounded to the nearest digit and therefore may
not always add up to 100%.
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every patient. ICD-9 codes for the Deyo-Charlson
comorbidities, anxiety and depression were obtained
from linked Mayo Clinic electronic databases.
Bias
We anticipated non-response at both 2- and 5-years,
higher at 5- than 2-years. We minimized confounding
bias by including multiple covariates known or
suspected to be associated with use of ADL limitation or
pain after THA.
Sample size
Our plan was to assemble a large enough sample to
study without having too long a study period, therefore
we chose all eligible patients from 1993 to 2005. We did
not perform any formal sample size calculations.
Statistical analyses
We used univariate and multivariable logistic regression
models to assess the association of operative diagnosis
with the odds of moderate-severe ADL limitation and
moderate-severe pain at both 2- and 5-years post-
revision THA. Logistic regressions were performed using
a generalized estimating equations (GEE) approach to
adjust the standard errors for the correlation between
observations on the same subject due to both hips hav-
ing been replaced and/or multiple operations on the
same hip. The multivariable model included age, gender,
BMI, ASA class, anxiety, depression, Deyo-Charlson
index, distance from the medical center and preoperative
limitation in 7 activities or preoperative pain (in respect-
ive models). Odds ratios (ORs) with 95% confidence
intervals (CIs) were calculated. A p-value ≤ 0.05 was
considered statistically significant. We decided a priori to
perform only four multivariable analyses for moderate-
severe ADL limitation and moderate-severe pain at 2- and
5-years to avoid multiple comparisons, which would be
needed, had we chosen individual ADLs as outcomes.
Descriptive univariate analyses of each ADL were
examined as exploratory analyses and presented in an
Additional file 1. Sensitivity analyses were performed for
the ADL limitation outcome (significantly associated), by
adjusting the main multivariable-adjusted model addition-
ally for ipsilateral knee involvement (model 1) or for
ipsilateral knee involvement and preoperative index hip
pain (model 2).
Results
The 2- and 5-year revision THA cohorts had a mean age of
66 and 65 years, 54% and 54% were female, and 30% and
32% were younger than 60 years of age respectively. BMI
was ≥40 kg kg/m2 in 7% and 6% and ASA score was class
I/II in 52% and 57% respectively (Table 1). The operativediagnosis was loosening, wear or osteolysis in 73% and
75%; dislocation, bone or prosthesis fracture, instability
or non-union in 17% and 15%; and failed prior
arthroplasty with components removed or infection in
11% and 11%, respectively (Table 1).
Compared to non-responders, responders at 2-years
post-revision THA were less likely to have BMI 35–
39.9 (compared to BMI < 25), higher Deyo-Charlson
index, ASA class III-IV, and operative diagnoses of dis-
location/fracture or failed arthroplasty with compo-
nents removed/infection (Additional file 1). At 5-years,
compared to non-responders, post-revision THA res-
ponders were less likely to have ASA class III-IV, higher
Deyo-Charlson index, and operative diagnoses of dis-
location/fracture or failed arthroplasty with compo-
nents removed/infection.
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living (ADLs) and pain
At 2-year and 5-years post revision THA, moderate-
severe overall ADL limitation was reported by 51% and
53% with loosening/wear/osteolysis, 66% and 65% with
dislocation/fracture/instability/non-union, and 68% and
65% with failed prior arthroplasty/infection (Table 2).
Moderate-severe pain at 2- and 5-years was reported by
18% and 19%, 18% and 23% and 18% and 23%, respec-
tively (Table 2). Limitation in each ADL is shown in
Additional file 1.
Compared to patients with loosening/wear/osteolysis,
patients in the other two operative diagnoses categories
were twice as likely to report moderate-severe overall
ADL limitation 2-years after revision THA (Table 2). At
5-years, patients in either of the two diagnostic catego-
ries were 1.6-times as likely to report moderate-severe
ADL limitation each, respectively. There were no signifi-
cant differences in moderate-severe pain by diagnostic
category at 2- and 5-years after revision THA (Table 2).
Multivariable-adjusted analyses
In analyses adjusted for 15-additional variables including
preoperative limitations in 7 ADLs, compared to patients
with loosening/wear/osteolysis, patients with dislocation/
fracture/instability/non-union had significantly higher
odds (2.2-times; p = 0.002) of moderate-severe ADL limi-
tation at 2-years post-revision THA (Table 3); those with
failed prior arthroplasty/infection showed a trend towards
significance with odds ratio of 1.6 (p = 0.06). At 5-years,
differences were no longer significant for moderate-severe
ADL limitation by diagnosis, after multivariable adjust-
ment. As in the unadjusted analyses, moderate-severe pain
did not differ significantly by diagnostic category, at 2- or
5-years in multivariable adjusted analyses, with oneTable 2 Unadjusted association of diagnosis with moderate-s
revision THA
2-years
n/N (%) OR 95%
Moderate-severe overall
limitations
Loosening/Wear or Osteolysis 940/1862 (50.5%) 1.0 (Ref)
Dislocation, Bone or Prosthesis
Fracture, Instability, Non-Union
279/423 (66%) 1.9 (1.5,
Failed Prior Arthroplasty with
Components Removed or Infection
185/274 (67.5%) 2.0 (1.6,
Moderate-severe pain
Loosening/Wear or Osteolysis 329/1872 (17.6%) 1.0 (Ref)
Dislocation, Bone or Prosthesis
Fracture, Instability, Non-Union
75/416 (18%) 1.0 (0.8, 1
Failed Prior Arthroplasty with
Components Removed or Infection
47/265 (17.7%) 1.0 (0.7, 1
Ref Reference category, OR odds ratio, 95% CI 95% confidence interval, OR odds rat
Bold represents significant odds ratio with p–value <0.05.exception, i.e. failed prior arthroplasty/infection had a
trend towards significance with odds ratio of 1.9 (p = 0.07).
Sensitivity analyses that additionally adjusted for ipsi-
lateral knee involvement (model 1) and ipsilateral knee
involvement and preoperative index THA pain severity
(model 2) showed that the interpretation or significance
level did not change for the associations with moderate-
severe ADL limitations at 2-years (Table 4).
Discussion
We found that operative diagnosis for revision THA was
associated with overall moderate-severe ADL limitation
in univariate analyses at both 2- and 5-years, but not
moderate-severe pain. The associations between opera-
tive diagnosis and ADL limitations remained significant
at 2-years after multivariable adjustment for variables
including preoperative limitations. Associations were not
significant at 5-years for moderate-severe ADL limita-
tions in multivariable-adjusted analyses. Several findings
in this study merit further discussion.
We found that operative diagnoses other than loosen-
ing/wear/osteolysis were independently associated with
poorer functional outcome, moderate-severe ADL limi-
tation 2-years after revision THA. This is an interesting
finding and supports the previous finding from a study
of 222 patients that underwent revision THA that
reported better functional outcome (WOMAC function
score) in patients with aseptic loosening at 1–2 year
follow-up compared to other diagnoses including infec-
tion, instability or fracture [4]. The previous study
adjusted for age, gender, body mass index, Charnley
class, pre-operative WOMAC function and pain scores,
preoperative SF-12 mental component score and various
implant and surgery related factors. Similarly, our study
adjusted for a variety of demographic, clinical and healthevere ADL limitation and moderate-severe pain after
5-years
CI p-value n/N (%) OR 95% CI p-value
616/1158 (53.2%) 1.0 (Ref)
2.4) <0.01 147/228 (64.5%) 1.6 (1.2, 2.2) <0.01
2.7) <0.01 108/166 (65.1%) 1.6 (1.2, 2.3) <0.01
216/1159 (18.6%) 1.0 (Ref)
.4) 0.83 51/226 (22.6%) 1.3 (0.9, 1.8) 0.17
.4) 0.95 38/166 (22.9%) 1.3 (0.9, 1.9) 0.19
io.
Table 3 Multivariable-adjusted association of diagnosis with overall moderate-severe limitation and moderate-severe
pain 2- and 5-years after revision THA
2-years 5-years
OR 95% CI p-value OR 95% CI p-value
Moderate-severe overall ADL limitationa
Loosening, Wear or Osteolysis* 1.0 (Ref) 1.0 (Ref)
Dislocation, Bone or Prosthesis Fracture, Instability, Non-Union 2.2 (1.3, 3.5) 0.002 1.4 (0.8, 2.6) 0.24
Failed Prior Arthroplasty with Components Removed or Infection 1.6 (1.0, 2.8) 0.06 1.1 (0.6, 2.0) 0.79
Moderate-severe painb
Loosening, Wear or Osteolysis* 1.0 (Ref) 1.0 (Ref)
Dislocation, Bone or Prosthesis Fracture, Instability, Non-Union 0.7 (0.4, 1.4) 0.32 1.0 (0.5, 2.1) 0.98
Failed Prior Arthroplasty with Components Removed or Infection 1.2 (0.7, 2.2) 0.48 1.9 (0.9, 3.8) 0.07
*Reference category: Loosening/Wear or Osteolysis.
aMain ADL limitation model was adjusted for 15 covariates/confounders: Age, gender, BMI, ASA class, distance from the medical center, anxiety, depression, Deyo-
Charlson index, preoperative limitation in 7 activities.
bAdjusted for 9 additional covariates/confounders: Age, gender, BMI, Deyo-Charlson comorbidity score, ASA class, distance from the medical center, anxiety,
depression and preoperative pain.
Bold represents significant odds ratio with p–value <0.05.
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size (10- and 5-times for 2- and 5-year samples respec-
tively), examined pain and function outcomes at both 2-
and 5-years and examined three diagnoses categories
(compared to two diagnoses categories in previous
study). Thus, our study extends the findings from this
previous study.
We found that diagnosis of dislocation/fracture/in-
stability/non-union and failed prior arthroplasty/infec-
tion were associated with 2- and 1.6-times the risk of
moderate-severe ADL limitation 2-years post-revision
THA. These findings confirm those findings from a
recent study with a small sample size that found that
functional improvements were lower in patients with
infection compared to patients with mechanical or pain
causes for revision hip arthroplasty [5]. Our study
extends findings from an inpatient setting to 2-years
post-revision THA. Diagnosis other than loosening/
wear/osteolysis may lead to a lower compliance with
post-THA rehabilitation given a more challenging early
postoperative course for these patients and possibly
higher rates of muscle atrophy prior to surgery. SinceTable 4 Sensitivity analyses for moderate-severe ADL limitati
models
OR
Model 1: Main ADL limitation modela additiona
Dislocation, Bone or Prosthesis Fracture, Instability, Non-Union 2.5
Failed Prior Arthroplasty with Components Removed or Infection 1.5
Model 2: Main ADL limitation modela additionally adjuste
Dislocation, Bone or Prosthesis Fracture, Instability, Non-Union 2.3
Failed Prior Arthroplasty with Components Removed or Infection 1.4
Main Model Adjusted for 15 covariates/confounders: Age, gender, BMI, ASA class, d
preoperative limitation in 7 activities.
Bold represents significant odds ratio with p–value <0.05.our analyses already adjusted for preoperative limitation,
differences in preoperative status don’t explain these
findings. Thus, our results extend the findings from the
previous study, and add to the current literature.
An interesting observation was that while diagnosis
was associated with ADL limitation, it was not signifi-
cantly associated with moderate-severe pain at 2- or 5-
years, in unadjusted or adjusted analyses. This indicates
uncoupling of ADL limitation and pain outcomes, indi-
cating different mechanisms for these some what corre-
lated, but different domains and outcomes. This implies
that patients undergoing revision THA can expect simi-
lar good results for pain, regardless of the opertative
diagnosis for undergoing revision THA. One exception
was that a diagnosis of failed prior arthroplasty/infection
was associated with an odds ratio of 1.9 for moderate-
severe pain at 5-years with a trend towards significance
(p = 0.07), compared to loosening/wear/osteolysis.
Our findings must be interpreted considering study
limitations. Despite our attempt to control for multiple
factors, residual confounding is possible, due to cohort
study design. It remains to be seen whether our findingson additionally adjusting the main multivariable-adjusted
2-years 5-years
95% CI p-value OR 95% CI p-value
lly adjusted for ipsilateral knee involvement
(1.4, 4.4) 0.003 1.6 (0.7, 3.4) 0.25
(0.8, 2.9) 0.22 1.4 (0.7, 3.0) 0.39
d for ipsilateral knee involvement, preoperative pain
(1.3, 4.3) 0.006 1.7 (0.8, 3.7) 0.17
(0.7, 2.7) 0.36 1.3 (0.6, 2.9) 0.46
istance from the medical center, anxiety, depression, Deyo-Charlson index,
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however, clinical and demographic characteristics of our
study cohort were similar to other cohorts in the pub-
lished studies of revision THA. Non-response may have
biased our results towards null, meaning that we may
have missed some significant findings. The non-response
rate was higher at 5-years, which makes those findings
potentially more biased.
Our study has several strengths including a large
sample size (>5-times most previous studies), analyses of
prospectively collected data, examination of both pain
and ADL limitations at 2-and 5-years, multivariable-
adjusted analyses accounting for multiple covariates and
confounders, and several sensitivity analyses that con-
firmed the robustness of our findings.Conclusions
In conclusion, in this study, we found that compared to
loosening/wear/osteolysis, operative diagnosis of disloca-
tion/fracture/instability/non-union and failed prior arthro-
plasty/infection were each associated with higher risk of
moderate-severe ADL limitation at 2-years. We did not
observe any significant association between operative
diagnosis and moderate-severe pain. The findings from
our study can be used to better inform the patients
about expected pain and function outcomes of revision
THA. More work is needed to assess the reasons as to
why the operative diagnosis is associated with ADL
limitations and not pain in patients undergoing revi-
sion THA.Additional file
Additional file 1: Appendix 1. Non-responder characteristics revision
THA. Appendix 2. Univariate association of Diagnosis with limitation of
each activity.Abbreviations
THA: Total hip arthroplasty; BMI: Body mass index; ASA: American society of
anesthesiologists; ICD-9: International classification of diseases- ninth revision;
GEE: Generalized estimating equations.
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